A number of stocks considered to be GLP-1 losers got hit after Dexcom. Unfortunately, seems like ResMed is still in that basket. In the previous earnings call ReaMed warned that the margin will come down a bit due to increased shipping costs, but if there a bigger drop and/or weak revenue, earnings or guidance the share price will be attacked hard. In other words anything but a perfect quarterly and the share price goes down.
Why the drop?, page-74
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$36.20 |
Change
0.190(0.53%) |
Mkt cap ! $23.26B | |||
| Open | High | Low | Value | Volume |
| $35.85 | $36.23 | $35.76 | $38.57M | 1.069M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7844 | $36.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $36.25 | 6003 | 3 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| RMD (ASX) Chart |